StockData
Utah Medical Products Inc logo

Utah Medical Products Inc (UTMD) stock

UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/306% below fair value
$71.97−1.66 (-2.25%)

Close on Nov 13, 2026Market cap $229.14MP/E 21.5Yield –

Utah Medical Products cash

Cash and short-term investments held at the end of each period.

Utah Medical Products's cash was $85.20M at Sep 30, 2026. For fiscal 2025 it was $85.76M, up 3.4% from the year before. Over ten years it grew 13.9% a year on average. The highest annual figure on record is $92.87M in fiscal 2023.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$85.76M+3.4%
FY2024Dec 31, 2024$82.98M-10.7%
FY2023Dec 31, 2023$92.87M+23.7%
FY2022Dec 31, 2022$75.05M+23.1%
FY2021Dec 31, 2021$60.97M+18.2%
FY2020Dec 31, 2020$51.59M+20.6%
FY2019Dec 31, 2019$42.79M-16.3%
FY2018Dec 31, 2018$51.11M+28.2%
FY2017Dec 31, 2017$39.88M+51.6%
FY2016Dec 31, 2016$26.30M+13.0%
FY2015Dec 31, 2015$23.28M+20.8%
FY2014Dec 31, 2014$19.27M+33.9%
FY2013Dec 31, 2013$14.40M+62.3%
FY2012Dec 31, 2012$8.87M+35.8%
FY2011Dec 31, 2011$6.53M+71.1%
FY2010Dec 31, 2010$3.82M+831.2%
FY2009Dec 31, 2009$410.00K+322.7%
FY2008Dec 31, 2008$97.00K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$85.20M+1.1%
Q2 FY2026Jun 30, 2026$87.53M+6.5%
Q1 FY2026Mar 31, 2026$87.41M+4.9%
Q4 FY2025Dec 31, 2025$85.76M+3.4%
Q3 FY2025Sep 30, 2025$84.27M-9.3%
Q2 FY2025Jun 30, 2025$82.18M-6.8%
Q1 FY2025Mar 31, 2025$83.33M-1.5%
Q4 FY2024Dec 31, 2024$82.98M+2.6%
Q4 FY2023Dec 31, 2023$92.87M+23.7%
Q3 FY2023Sep 30, 2023$88.21M+26.9%
Q2 FY2023Jun 30, 2023$84.62M+27.8%
Q1 FY2023Mar 31, 2023$80.91M+22.8%
Q4 FY2022Dec 31, 2022$75.05M+23.1%
Q3 FY2022Sep 30, 2022$69.51M+8.1%
Q2 FY2022Jun 30, 2022$66.22M+11.3%
Q1 FY2022Mar 31, 2022$65.87M+17.6%
Q4 FY2021Dec 31, 2021$60.97M+18.2%
Q3 FY2021Sep 30, 2021$64.32M+38.9%
Q2 FY2021Jun 30, 2021$59.51M+40.5%
Q1 FY2021Mar 31, 2021$56.03M+41.5%
Q4 FY2020Dec 31, 2020$51.59M+20.6%
Q3 FY2020Sep 30, 2020$46.29M+23.8%
Q2 FY2020Jun 30, 2020$42.35M+28.8%
Q1 FY2020Mar 31, 2020$39.61M+21.3%
Q4 FY2019Dec 31, 2019$42.79M-16.3%
Q3 FY2019Sep 30, 2019$37.39M-24.2%
Q2 FY2019Jun 30, 2019$32.88M-28.3%
Q1 FY2019Mar 31, 2019$32.67M-23.8%
Q4 FY2018Dec 31, 2018$51.11M+28.2%
Q3 FY2018Sep 30, 2018$49.35M+31.8%
Q2 FY2018Jun 30, 2018$45.87M+36.0%
Q1 FY2018Mar 31, 2018$42.85M+39.7%
Q4 FY2017Dec 31, 2017$39.88M+51.6%
Q3 FY2017Sep 30, 2017$37.44M+18.6%
Q2 FY2017Jun 30, 2017$33.74M+14.8%
Q1 FY2017Mar 31, 2017$30.68M+11.5%
Q4 FY2016Dec 31, 2016$26.30M–
Q3 FY2016Sep 30, 2016$31.56M–
Q2 FY2016Jun 30, 2016$29.40M–
Q1 FY2016Mar 31, 2016$27.52M–

More Utah Medical Products figures

See a number that looks wrong?